Lim Research Group
Biophysics of A Complex Dynamic Systems | Department of Biosystems Engineering | Kangwon National University | South KOREA
Ki-Taek Lim, Ph.D.
-
Associate Professor | Biosystems Engineering, KNU (home)
Affiliated Professor | KIIT (Kangwon Institute of Inclusive Technology), KNU (joined)
Affiliated Professor | Interdisciplinary Program in Smart Agriculture, KNU (joined)
Affiliated Professor | The Institute of Forest Science, KNU (joined)
Visiting Scholar | Research Institute of Agriculture and Life Sciences, SNU (joined)
CLICK: Biographical Sketch
Email: ktlim@kangwon.ac.kr
Office: Bldg 307 Rm 205
Phone: +82-33-250-6491
ORCID: https://orcid.org/0000-0003-2091-788X
Research-at-a-glance:
-
Stem cell-reactor automated system
-
3D bioprinted drug delivery hydrogel patches
-
Cell therapeutics based on tissue engineering and regenerative medicine
-
Cancer therapy based on Bio/Nano-technology applications
-
NK cell-derived exosome cancer immunotherapy
-
A simple test kit for the detection of nanoparticles
-
4D printing for science robotics
Biography:
-
Prof. Lim completed his undergraduate degrees in Biosystems Engineering at Konkuk University and an MA in Biomechatronics from Sungkyunkwan University. Ki-Taek continued his doctoral studies in Biosystems Engineering at Seoul National University under the joint supervision of Prof. Jong Hoon Chung. He held a postdoctoral appointment at Dental Research Institute, Seoul National University where he developed high-throughput automated culture platforms via a bioreactor process engineering for enhanced tissue regeneration from stem cells in Prof. Pill-Hoon Choung’s laboratory, plus, he developed nanoparticles as tools to control stem cells in Prof. Jin-Woo Kim’s Bio/Nano-Technology Group, Institute for Nanoscience and Engineering, University of Arkansas, Fayetteville. Ki-Taek joined KNU as an Assistant Professor of Biosystems Engineering in Feb. 2015, with getting along with an Adjunct Professor and a Visiting Scholar at SNU (Seoul National University)
Research:
-
Broadly, research in the Lim group integrates new bioreactor process, optical, and bio/nano-technology tools for application in biology and agricultural engineering. We pioneer the bio-convergence system in biosystems engineering approaches, aiming to enable multi-parametric studies with the power to reveal the workings of natural and engineered biological systems.
Research Areas:
-
Bioreactor Engineering/Automated Bioreactor System: Engineering Parameters in Bioreactor’s Design
-
Automation and -Robotics for Biological Engineering
-
Tissue Engineering and Regenerative Medicine
-
Bioceramics for Bone Tissue Engineering
-
Stem Cell Culture Technologies & Convergence Engineering based on 3D Printing & Micro-Nano Platforms
-
Pathogen Detection Systems using fully automated-on site microbiological testing productions.
BIOMECHAGEN CO.,LTD
Biomechagen is pioneering the development of a new class of specific therapeutic nanoengineering healingforms. Our new technology platform is based on the discovery of exosome functions s to block the immune processes causing immune-mediated diseases. Biomechagen is a privately held biotechnology company focused on the discovery, development and commercialization of novel anti-infectives for the treatment of diseases that are inadequately addressed by current standard-of-care therapies. Biomechagen's initial portfolio is comprised of long-acting antifungal product candidates, exosome-skincare and its healing nanohydrogel patches for the treatment of serious fungal infections. In addition, Biomechagen has developed a proprietary immunotherapy platform, HydrogelBG, designed to create antifungals, antibacterials and antivirals that direct a patient's immune cells to attack and eliminate pathogens that cause infectious disease.
Biomechagenis headquartered in Chuncheon, South Korea.
Synergistic Platforms of Next-Generation
